An analysis of recent returns from venture-backed biotech firms reveals that companies receiving the most financing do not necessarily deliver the best returns.
引用
收藏
页码:854 / 858
页数:5
相关论文
共 3 条
[1]
Booth BL, 2006, NAT BIOTECHNOL, V24, P1335, DOI 10.1038/nbt1106-1335